Compare SCSC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCSC | CDNA |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.6B |
| IPO Year | 1997 | 2007 |
| Metric | SCSC | CDNA |
|---|---|---|
| Price | $56.96 | $50.03 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $43.00 | $28.00 |
| AVG Volume (30 Days) | 288.4K | ★ 983.3K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.33 | N/A |
| EPS | ★ 3.64 | 2.13 |
| Revenue | ★ $3,846,260,000.00 | $48,324,000.00 |
| Revenue This Year | $2.60 | $16.01 |
| Revenue Next Year | $4.01 | $11.31 |
| P/E Ratio | ★ $15.85 | $23.62 |
| Revenue Growth | 7.79 | ★ 18.93 |
| 52 Week Low | $33.76 | $13.39 |
| 52 Week High | $66.78 | $53.67 |
| Indicator | SCSC | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 62.38 |
| Support Level | $49.77 | $45.74 |
| Resistance Level | $59.46 | $53.67 |
| Average True Range (ATR) | 2.56 | 2.49 |
| MACD | 0.18 | -0.44 |
| Stochastic Oscillator | 28.61 | 60.59 |
ScanSource Inc is a technology distributor uniquely positioned to address complex, converging technologies and to accelerate growth for channel sales partners across hardware, SaaS, connectivity, and cloud. The Company provides technology solutions and services from suppliers of mobility and barcode, POS, payment terminals, physical security, networking, communications, connectivity, and cloud services to channel sales partners located mainly in the United States and Brazil. It has two reportable segments based on the sales model: Specialty Technology Solutions, which generates maximum revenue and includes hardware, SaaS, and subscription services through a wholesale/resale sales model, and Intelisys & Advisory. Geographically, it derives the majority of its revenue from the United States.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.